The Effect of Halo‐Pelvic Traction on Bone Mineral Density of Vertebrae and Corresponding Risk Factors
Orthopaedic Surgery · 2023
DOI: 10.1111/os.13858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthopaedic Surgery, 2023. Verfasst von Xianming Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Scoliosis, Kyphosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Decreased bone mineral density (BMD) is associated with complications in implantation surgery for severe spinal deformity. In this quantitative study, we aimed to investigate the impact of halo‐pelvic traction on vertebral bone mineral density (BMD) and identify the risk factors for a decrease in BMD.
Methods
Patients who underwent halo‐pelvic traction at our hospital between 2019 and 2022 were included in the study. Patients’ data, including height, weight, and BMD pre‐ and post‐traction, were collected and analyzed. Quantitative computed tomography (QCT) was used to determine the BMD. The paired rank sum test was used to evaluate the changes in each measurement parameter. Linear regression was used to identify risk factors for a decrease in BMD.
Results
Fifteen patients were included in the study, nine women and six men, with an average age of 21.2 ± 7.3 years. Eleven patients had severe rigid scoliosis, while four had tuberculotic kyphosis. One expert measured the BMD values of 345 vertebrae using QCT. The average traction time was 143.3 ± 44.4 days. The average pre‐traction BMD was 183.1 ± 73.8 mg/cm 3 , and the average post‐traction BMD was 140.5 ± 61.3 mg/cm 3 ( p < 0.01) Patients’ height increased from an average of 151.3 ± 12.8 cm pre‐traction to 165.5 ± 13.7 cm post‐traction ( p < 0.01), with traction length averaging 14.3 ± 6.2 cm ( p < 0.01). The Cobb angle of the main curve declined from an average of 112.5° ± 24.4° pre‐traction to 67.7° ± 19.8° post‐traction ( p < 0.01). Linear regression revealed a positive correlation between BMD loss and traction length and a negative correlation between BMD loss and correction rate.
Conclusions
Halo‐pelvic traction can lead to a decrease in the BMD of the spinal vertebrae, with traction length positively correlated with BMD loss and correction rate negatively correlated with BMD loss. To prevent osteoporosis, physicians should ensure a limited traction length while utilizing better management techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, West China Hospital, Sichuan University, Chengdu, China.
- Department of Orthopaedics, Xinqiao Hospital of Army Medical University, Chongqing, China.
- Department of Pediatric Surgery, Dazhou Central Hospital, Dazhou, China.
- Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Xianming Huang, Peng Xiu, Yi Shu, Yueming Song, Zhongjie Zhou, Chunguang Zhou, Ganjun Feng, Lei Wang, Limin Liu, Jing Tang, Xi Yang
Zitieren
APA
Huang, X., Xiu, P., Shu, Y., Song, Y., Zhou, Z., Zhou, C., Feng, G., Wang, L., Liu, L., Tang, J., & Yang, X. (2023). The Effect of Halo‐Pelvic Traction on Bone Mineral Density of Vertebrae and Corresponding Risk Factors. Orthopaedic Surgery. https://doi.org/10.1111/os.13858
Vancouver
Huang X, Xiu P, Shu Y, Song Y, Zhou Z, Zhou C, et al. The Effect of Halo‐Pelvic Traction on Bone Mineral Density of Vertebrae and Corresponding Risk Factors. Orthopaedic Surgery. 2023. doi:10.1111/os.13858
BibTeX
@article{Huang2023,
author = {Huang, Xianming and Xiu, Peng and Shu, Yi and Song, Yueming and Zhou, Zhongjie and Zhou, Chunguang and Feng, Ganjun and Wang, Lei and Liu, Limin and Tang, Jing and Yang, Xi},
title = {The Effect of Halo‐Pelvic Traction on Bone Mineral Density of Vertebrae and Corresponding Risk Factors},
journal = {Orthopaedic Surgery},
year = {2023},
doi = {10.1111/os.13858}
}
EUVIMED